MiniVax was the winner of the 2013 BioChallenge, a pitch competition for emerging Louisiana bioscience startups. MiniVax is developing a treatment for a deadly fungal pneumonia that affects immunocompromised patients.

November 23, 2013 – Read it now in The Advocate